Nanodiamond-enabled biomedical imaging.

Biomedical imaging allows in vivo studies of organisms, providing valuable information of biological processes at both cellular and tissue levels. Nanodiamonds have recently emerged as a new type of probe for fluorescence imaging and contrast agent for magnetic resonance and photoacoustic imaging. Composed of sp3-carbon atoms, diamond is chemically inert and inherently biocompatible. Uniquely, its matrix can host a variety of optically and magnetically active defects suited for bioimaging applications. Since the first production of fluorescent nanodiamonds in 2005, a large number of experiments have demonstrated that fluorescent nanodiamonds are useful as photostable markers and nanoscale sensors in living cells and organisms. In this review, we focus our discussion on the recent advancements of nanodiamond-enabled biomedical imaging for preclinical applications.

Nanodiamond-supported silver nanoparticles as potent and safe antibacterial agents.

Since its discovery nearly a century ago, antibiotics has been one of the most effective methods in treating infectious diseases and limiting pathogen spread. However, pathogens often build up antibiotic resistance over time, leading to serious failure of the treatment. Silver nanoparticle (AgNP) is an appealing alternative, but successful treatment of the bacterial infection requires a plentiful supply of AgNP, which can negatively impact human health if people are excessively exposed to the particles. Here, we present a method to overcome this challenge by synthesizing nanodiamond-supported AgNP noncovalently conjugated with albumin molecules to achieve enhanced antibacterial activity and strengthened biocompatibility. Using Escherichia coli as a model bacterium, we found that the albumin-conjugated silver-diamond nanohybrids showed a long-term bactericidal effect after 36 days of the treatment at the AgNP concentration of 250 µg mL-1. Moreover, the toxicity of the nanohybrids to human cells (including human fibroblasts, lung adenocarcinoma epithelial cells, and breast adenocarcinoma cells) is low even at the particle concentration of 500 µg mL-1. The method provides a general and practical solution to the concerns of bacterial resistance against AgNP and issues associated with the size, shape, aggregation, and toxicity of AgNP are largely resolved. Finally, we demonstrate that the nanohybrids can be readily incorporated into natural polysaccharides (such as guar gum) to form three-in-one hydrogels, showing promising applications in nanomedicine.

Fluorescent nanodiamonds enable quantitative tracking of human mesenchymal stem cells in miniature pigs.

Cell therapy is a promising strategy for the treatment of human diseases. While the first use of cells for therapeutic purposes can be traced to the 19th century, there has been a lack of general and reliable methods to study the biodistribution and associated pharmacokinetics of transplanted cells in various animal models for preclinical evaluation. Here, we present a new platform using albumin-conjugated fluorescent nanodiamonds (FNDs) as biocompatible and photostable labels for quantitative tracking of human placenta choriodecidual membrane-derived mesenchymal stem cells (pcMSCs) in miniature pigs by magnetic modulation. With this background-free detection technique and time-gated fluorescence imaging, we have been able to precisely determine the numbers as well as positions of the transplanted FND-labeled pcMSCs in organs and tissues of the miniature pigs after intravenous administration. The method is applicable to single-cell imaging and quantitative tracking of human stem/progenitor cells in rodents and other animal models as well.